Myasthenia Gravis Market | Rising Prevalence Of Neuromuscular Disorders

According to Precision Business Insights (PBI), the latest report, the Myasthenia Gravis market is expected to be valued at USD 1,734.6 million in 2022, growing at an 8.1% CAGR from 2022 to 2028. The primary driver of the expansion of the global Myasthenia Gravis market increasing prevalence of neuromuscular disorders, and rising awareness about effective treatment.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/myasthenia-gravis-market/

Medication Segment to Dominate the Myasthenia Gravis Market:
Among the treatments, medication held a significant market share and is expected to maintain its dominancy over the forecast period owing to medications can dramatically inhibit the immune system and mostly accomplish the associated symptoms. Medications include immunotherapies such as Soliris (eculizumab), immunosuppressive drugs, prograf (tacrolimus) corticosteroids, and neoral/Sandimmune (cyclosporine).

North America Myasthenia Gravis Market:
The North America market is expected to lead the global Myasthenia Gravis market over the forecast period attributed to the better facilities present in the clinical setups in this region. According to the report given by the Myasthenia Gravis Foundation of America, the prevalence of MG disease is estimated to be 14 to 20 people out of every 100,000 people in the United States. Furthermore, the increasing prevalence of the disease in the region is also expected to contribute to the growth of the market in the coming years. On the other hand, the Asia Pacific region is expected to grow with a significant revenue share over the forecast period in the Myasthenia market owing to increased government and private sector hard work to develop effective treatments, rising public awareness of neuromuscular disorders, and advancements in the healthcare infrastructure.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=60763

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global Myasthenia Gravis market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region.

The myasthenia gravis market is segmented based on treatment, end user, and geography.
Based on the treatment, the market is segmented into the following:
• Surgery
• Medication
• Others

Based on the end user, the market is segmented into the following:
• Hospitals
• Clinics
• Others

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=60763

Key players' profiles in the myasthenia gravis market report are Alexion Pharmaceutical Inc. (U.S.), Bausch Health Companies Inc. (Canada), Grifols SA (Spain), Avadel Pharmaceuticals plc. (France), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), AbbVie Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline plc (U.K.), and Shire plc (U.S.)

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.